Improved Model for Predicting Axillary Response to Neoadjuvant Chemotherapy in Patients with Clinically Node-Positive Breast Canceropen access
- Authors
- Kim, Hyung Suk; Shin, Man Sik; Kim, Chang Jong; Yoo, Sun Hyung; Yoo, Tae Kyung; Eom, Yong Hwa; Chae, Byung Joo; Song, Byung Joo
- Issue Date
- Dec-2017
- Publisher
- 한국유방암학회
- Keywords
- Axilla; Breast neoplasms; Lymph nodes; Neoadjuvant therapy
- Citation
- Journal of Breast Cancer, v.20, no.4, pp.378 - 385
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Journal of Breast Cancer
- Volume
- 20
- Number
- 4
- Start Page
- 378
- End Page
- 385
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/150965
- DOI
- 10.4048/jbc.2017.20.4.378
- ISSN
- 1738-6756
- Abstract
- Purpose
Pathological complete response (pCR) of axillary lymph node (LN) is frequently achieved in patients with clinically node-positive breast cancer after neoadjuvant chemotherapy (NAC). Treatment of the axilla after NAC is not well established and the value of sentinel LN biopsy following NAC remains unclear. This study investigated the predictive value of axillary response following NAC and evaluated the predictive value of a model based on axillary response.
Methods
Data prospectively collected on 201 patients with clinically node-positive breast cancer who were treated with NAC and underwent axillary LN dissection (ALND) were retrieved. A model predictive of axillary pCR was developed based on clinicopathologic variables. The overall predictive ability between models was compared by receiver operating characteristic (ROC) curve analysis.
Results
Of 201 patients who underwent ALND after NAC, 68 (33.8%) achieved axillary pCR. Multivariate analysis using axillary LN pCR after NAC as the dependent variable showed that higher histologic grade (p=0.031; odds ratio [OR], 2.537; 95% confidence interval [CI], 1.087–5.925) and tumor response rate ≥47.1% (p=0.001; OR, 3.212; 95% CI, 1.584–6.515) were significantly associated with an increased probability of achieving axillary pCR. The area under the ROC curve for estimating axillary pCR was significantly higher in the model that included tumor response rate than in the model that excluded this rate (0.732 vs. 0.649, p=0.022).
Conclusion
Tumor response rate was the most significant independent predictor of axillary pCR in response to NAC. The model that included tumor response rate was a significantly better predictor of axillary pCR than the model that excluded tumor response rate.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 외과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/150965)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.